Amy Clark
Abramson Cancer Center at Penn Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amy Clark as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 18:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04523857 · ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast CancerAbramson Cancer Center at Penn Medicine · recruiting · Breast Cancer · principal investigator
- Ph1NCT02599363 · A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast CancerAbramson Cancer Center at Penn Medicine · completed · Advanced Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 18:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 18:57 UTC. The ranking covers the 200 most relevant of 390 PubMed records, and a shared surname and initials can bring in a namesake. All 390 on PubMed
- 620 citationsRCR 24.3
- Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.N Engl J Med · 2022467 citationsRCR 37.6
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.Cancer Immunol Res · 2017398 citationsRCR 11.6
- Therapeutic hypothermia after out-of-hospital cardiac arrest in children.N Engl J Med · 2015334 citationsRCR 14.9
- Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.Cancer Cell · 2021307 citationsRCR 13.7
- Bone response to termination of oestrogen treatment.Lancet · 1978294 citationsRCR 12.0
- Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial.JAMA Intern Med · 2019222 citationsRCR 14.4
- Therapeutic Hypothermia after In-Hospital Cardiac Arrest in Children.N Engl J Med · 2017220 citationsRCR 10.1
- Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.Eur Heart J · 2014209 citationsRCR 8.2
- Prospective controlled trial of injection sclerotherapy in patient with cirrhosis and recent variceal haemorrhage.Lancet · 1980187 citationsRCR 10.1